Based on the SURPASS-CVOT trial, tirzepatide is now the first GIP/GLP-1 drug with a label for cutting major cardiovascular events in this group.
Recap by typeshit. Full story at GreaterGood.
Novo reports nine-month results on Nov. 4, after a US judge declined its request to pause Lilly's weight-loss drug ads while the marketing dispute continues.
The Urban Zakapa singer shared gym-bound photos captioned with a call to go work out, as she focuses on exercise to hold her weight after stopping Wegovy.
The fitness creator argues people chase shortcuts and should handle walking, tracking food, water and 7 to 9 hours of sleep before adding peptides.
The Wegovy-sponsored CFL Division Finals kick off November 7 at 3:00 PM ET, the next step on the road to the Grey Cup.
The National Pharmacy Association reports fake obesity cases, and the GPhC regulator says pharmacists who fail to verify weight will face sanctions.
The This Is Us actress says the drug eased her inflammation and quieted food noise, after losing 100 pounds last year.
Loading…